Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Yinnuoke Pharmaceutical Group is a large-scale pharmaceutical enterprise headquartered in Changchun, China, that integrates drug research, development, production, and sales. The company maintains a diverse portfolio of over 100 products, ranging from modernized Traditional Chinese Medicines (TCM) to chemical generics and health supplements. Its core therapeutic strengths lie in cardiovascular health, respiratory medicine, and pediatrics, with multiple GMP-certified production lines for capsules, tablets, and granules. As a recognized high-tech enterprise in Jilin Province, Yinnuoke focuses on the industrialization of herbal medicine and the production of essential chemical drugs for the domestic Chinese market. The group operates several subsidiaries and maintains an extensive distribution network across mainland China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Yinnuoke Pharmaceutical.